Poor
Not Aligned
Patient Risk:
Low
Summary
All 16 user-provided color-based claims are not supported by the FDA-approved label content provided (Information for Patients).
Category Scores
Accurate Statements
Unsupported Statements
There is no single universal 'codeine color'.
absent_from_label
The color depends on the manufacturer and country.
absent_from_label
The color depends on the formulation (tablet vs. syrup vs. extended-release).
absent_from_label
The strength (e.g., different mg amounts are often different colors).
absent_from_label
The color depends on inactive ingredients (dyes, coatings, fillers).
absent_from_label
Color alone is not reliable for identifying codeine strength.
absent_from_label
Color alone is not reliable for determining whether a product contains codeine.
absent_from_label
Counterfeit or misbranded products may use similar colors to legitimate medicines.
absent_from_label
Street mixtures may contain other substances, different doses, or no codeine at all.
absent_from_label
Color can vary between batches and over time for the same brand/strength.
absent_from_label
If there’s any chance a product is untrusted or unidentified, it is safer to treat it as unknown rather than try to verify by color.
absent_from_label
The label (drug name and strength, mg per tablet or mg per mL) is a reliable identifier.
absent_from_label
Imprint code or marking on the tablet (if present) is a reliable identifier.
absent_from_label
Packaging and pharmacy information are reliable identifiers.
absent_from_label
Do not take an unknown product based on appearance.
absent_from_label
If this is a medical need (pain, cough, etc.), use only prescriptions or pharmacy-labeled products.
absent_from_label
If someone has taken an unknown opioid-containing product or an overdose is possible, seek emergency help immediately.
absent_from_label
Contradictions
Important Omissions
The label does not provide explicit guidance tying color to codeine content or strength, nor explicit cautions about counterfeit-identification via color; no direct statement about relying on color as a safety measure.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The claims assessed are about color-based product identification and counterfeit risk, which are not described in the Information for Patients as color-based identifiers. No new safety signal is introduced by the claims themselves.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Not Aligned
Primary Issue
Claims about color-based identification of codeine are not supported by the provided FDA label content.
Suggested Improvement
Limit statements to those supported by the label; avoid color-based identifiers or counterfeit-risk claims unless explicitly described in the label.